Zimmer Holdings (NYSE: ZMH) announced its results for the third quarter on October 27, 2011. Let's take a closer look at the company's industry, financials, and commentary and see what steps you can take next.
Earnings and Revenue:
Zimmer Holdings' EPS topped estimates and revenues came in line with Wall Street's expectations. The company reported adjusted net income of $1.04/share versus the $1.03/share estimate and revenues of $1.03 billion versus the $1.03 billion estimate. Revenue climbed 6.9% from the same period last year.
Last quarter marked the third in a row of rising net income. Zimmer Holdings' revenue has grown during each of the past four quarters on a year-over-year basis.
Income:
For the year, Zimmer Holdings reported net income of $4.71/share. The company trumped analyst projections of $4.56 by 3.3%. The company's income has remained about on par with last year's levels.
Conference Call:
The conference call for third quarter earnings can be accessed here.
Official Comment:
"Zimmer delivered against our financial commitments in the third quarter with consistent results in both revenues and earnings," said David Dvorak, Zimmer President and CEO."Progress in the commercialization of new products supported a strong performance in many international markets. Through this progress and ongoing financial discipline, we continue to deliver value to stockholders."
Industry:
The medical products company's industry is currently enjoying price/earnings growth of 1.5%.
What to Do Next:
Now that you've gotten a round up of Zimmer Holdings' latest numbers, you can make a better-informed decision about whether to buy, sell, or hold those shares. Whatever you do, be sure to visit us before the company's next earnings release for a full preview.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
